Oncology
Medicines
Euro Biom supplies UK-licensed oncology medicines to hospitals, oncology centres and healthcare institutions in the UK and overseas. Our portfolio includes cytotoxic chemotherapy, targeted agents, hormone therapies and oncology supportive care, with named-patient import supply available for cancer medicines not yet registered in your market.
Search Our Oncology Range
All medicines listed are UK-licensed and MHRA-authorised, sourced through the UK licensed supply chain; devices and test kits carry their UKCA or CE marking. Contact us to enquire about any product. Euro Biom trades exclusively in UK-licensed medicines and does not supply vaccines, biologics, biosimilars, insulin, blood products or controlled drugs.
Trade reference list for licensed healthcare organisations, distributors and procurement teams. Names, strengths and pack sizes are listed so buyers can request a quote. This is not a recommendation for any use. If you are a patient, please speak to your doctor or pharmacist. We cannot supply you directly.
Showing all 110 products
No products found. Contact us, we can likely source it.
Oncology Medicine Supply: Chemotherapy, Targeted Therapies & Named-Patient Import
Euro Biom can quote oncology medicines for NHS hospitals, international cancer centres and humanitarian oncology programmes, including UK-licensed products not yet registered in the buyer's market, subject to availability.
Our oncology range is listed by class. Cytotoxic chemotherapy includes platinum compounds (carboplatin, cisplatin, oxaliplatin), taxanes (paclitaxel, docetaxel), antimetabolites (methotrexate, capecitabine, fluorouracil, gemcitabine), anthracyclines (doxorubicin, epirubicin), alkylating agents (melphalan, chlorambucil), and vinca alkaloids (vincristine, vinblastine, vinorelbine).
Our oral targeted therapy range includes kinase inhibitors (imatinib, erlotinib, gefitinib, osimertinib, ibrutinib), the BCL-2 inhibitor venetoclax and CDK 4/6 inhibitors (palbociclib, ribociclib). Euro Biom can also quote hormone therapies, including aromatase inhibitors (letrozole, anastrozole, exemestane), anti-androgens (bicalutamide, enzalutamide, abiraterone), and SERM/SERD agents (tamoxifen, fulvestrant), subject to availability.
Where a product is not registered in your market, we can supply UK-licensed medicines for import under your country's named-patient or special import permit route. We can quote for oncology pharmacists and procurement teams in the UK, the GCC and sub-Saharan Africa.
Need a Specific Oncology Product?
Our team can source shortage and hard-to-source oncology medicines for named-patient import through our licensed supply network, with a same-day response to your enquiry.
Submit an Enquiry →